The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
Bristol-Myers Squibb Co. (BMY)

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co. has products in the following therapeutic classes: oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus infection. Co.'s products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. Co. manufactures products in the U.S., Puerto Rico and in four foreign countries. Co.'s products include: Opdivo; Eliquis; Orencia; Sprycel; Yervoy; Empliciti; Baraclude; the Sustiva Franchise; the Reyataz Franchise; and Hepatitis C Franchise.

Bristol-Myers Squibb SEC Filing Email Alerts Service

Company Name:  Bristol-Myers Squibb Co.
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding BMY:  86
Total Market Value Held by ETFs:  $3.16B
Total Market Capitalization:  $83.73B
% of Market Cap. Held by ETFs:  3.78%

February 23, 2019    3:52 PM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Buy (2.60 out of 4)
18th percentile
(ranked lower than approx. 82% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Bristol-Myers Squibb Co. (BMY) Page | The Online Investor | | Copyright © 1998 - 2019, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.